Signaling Pathways in Breast Cancer : Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance

個数:1
紙書籍版価格
¥42,062
  • 電子書籍

Signaling Pathways in Breast Cancer : Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance

  • 言語:ENG
  • ISBN:9780443490743
  • eISBN:9780443490750

ファイル: /

Description

Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance provides an in-depth exploration of the complex molecular mechanisms that drive breast cancer progression. The book focuses on critical signaling pathways, including PI3K/Akt/mTOR, MAPK/ERK, JAK/STAT, Wnt/β-catenin, and Notch, elucidating their roles in tumor development, survival, and therapeutic resistance. The content offers a comprehensive overview of these pathways, detailing their dysregulation in breast cancer and implications for targeted therapeutic strategies. It discusses FDA-approved treatments, emerging therapies, and the mechanisms behind drug resistance, integrating recent research findings to highlight novel molecular targets and biomarker discovery. This book serves as a valuable resource for researchers, clinicians, and students, bridging the gap between basic molecular biology and clinical applications. By providing structured insights into complex signaling networks and therapeutic interventions, it equips readers with essential knowledge for developing innovative approaches to breast cancer management and improving patient outcomes.- Provides a detailed exploration of critical signaling pathways such as PI3K/Akt, MAPK, JAK/STAT, and Notch, elucidating their roles in tumor initiation, progression, and resistance to therapy- Discusses FDA-approved targeted therapies and emerging treatment strategies, including immunotherapy and personalized medicine- Addresses mechanisms of drug resistance and potential strategies for overcoming resistance- Includes case studies and biomarker-based approaches that link molecular mechanisms to clinical outcomes- Offers insights into ongoing clinical trials and future directions in breast cancer therapy

Table of Contents

1. Introduction to Breast Cancer and Signaling Pathways2. Emerging Molecular Targets in Breast Cancer Therapy3. Role of Tumor Microenvironment in Breast Cancer Development4. Molecular Subtypes of Breast Cancer and Their Clinical Significance5. Key Signaling Pathways in Breast Cancer Progression6. RNA-Based Therapies: miRNA and siRNA in Breast Cancer Treatment7. Targeting Angiogenesis: VEGF and Its Inhibitors8. Antibody-Drug Conjugates (ADCs) in Breast Cancer Treatment9. Small Molecule Kinase Inhibitors: Current Status and Future Directions10. Nanotechnology and Precision Drug Delivery for Breast Cancer11. MDR and Strategies to Overcome Therapy Failure12. Combination Therapies for Overcoming Resistance in Breast Cancer13. Targeting Autophagy in Overcoming Multidrug Resistance14. Role of Biomarker-Based Therapeutic Approaches15. Role of CRISPR in Triple Negative Breast Cancer16. ERK Signaling and Breast Cancer17. Artificial Intelligence in Breast Cancer Therapy18. Role of Microbiota in Breast Cancer Progression and Therapy19. Heterogeneity and Drug Resistance in Breast Cancer20. Advancement Therapeutic Approaches in Drug Resistance Breast Cancer Management21. Bridging Theory and Practice in Breast Cancer: Case Studies and Clinical Insights22. Challenges and Innovations in Therapeutic Strategies in Treatment of Breast Cancer

最近チェックした商品